Muggia, F M <br/><br/>
Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology Group.  [electronic resource] 

 -  Gynecologic oncology  Jun 1996 
 - 395-402 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.1996.0163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Female<br/>Floxuridine--administration & dosage<br/>Humans<br/>Infusions, Parenteral<br/>Laparotomy<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Neoplasm, Residual<br/>Ovarian Neoplasms--drug therapy<br/>Reoperation<br/>Survival Analysis<br/>Treatment Outcome